title: Methotrexate for rheumatoid arthritis: what should the patient be told?
authors.forename: A J K
authors.initials: AJ
authors.lastname: Ostor
authors.forename: D R
authors.initials: DR
authors.lastname: O'Gradaigh
authors.forename: J R
authors.initials: JR
authors.lastname: Jenner
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000139:chemically induced*; D017809:Fatal Outcome; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D010353:Patient Education as Topic
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate